Knockdown strategies for the study of proprotein convertases and proliferation in prostate cancer cells

Methods in Molecular Biology

Volumn 1103, Issue , 2014, Pages 67-82

  D'Anjou, François ^a   Couture, Frédéric ^a   Desjardins, Roxane ^a   Day, Robert ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

HDV ribozyme; Lentivirus; MTT; Proprotein convertases; Prostate cancer; shRNA; Xenografts; XTT

Indexed keywords

ANTINEOPLASTIC AGENT; LENTIVIRUS VECTOR; MESSENGER RNA; PROPROTEIN CONVERTASE PACE 4; RIBOZYME; SERINE PROTEINASE; SHORT HAIRPIN RNA; SOFA HDV RIBOZYME; TETRAZOLIUM; UNCLASSIFIED DRUG; PCSK6 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RIBOZYME THERAPY; TUMOR XENOGRAFT; CELL CLONING; IN VIVO STUDY; PROTEIN EXPRESSION; ANIMAL; CELL PROLIFERATION; GENETICS; METABOLISM; METHODOLOGY; MOLECULAR BIOLOGY; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; MALE; MICE; MOLECULAR BIOLOGY; PROPROTEIN CONVERTASES; PROSTATIC NEOPLASMS; RNA, CATALYTIC; RNA, MESSENGER; RNA, SMALL INTERFERING; SERINE ENDOPEPTIDASES;

EID: 84892853041     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-730-3_6     Document Type: Article

References (28)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: The next generation. Cell 144: 646-674
2. Berridge MV, Herst PM, Tan AS (2005) Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction. Biotechnol Annu Rev 11:127-152
3. Cespedes MV, Casanova I, Parreno M, Mangues R (2006) Mouse models in oncogenesis and cancer therapy. Clin Transl Oncol 8: 318-329
4. D'Anjou F, Routhier S, Perreault JP, Latil A, Bonnel D, Fournier I, Salzet M, Day R (2011) Molecular validation of PACE4 as a target in prostate cancer. Transl Oncol 4:157-172
5. Seidah NG, Prat A (2012) The biology and therapeutic targeting of the proprotein convertases. Nat Rev Drug Discov 11:367-383
6. Seidah NG, Chretien M (1999) Proprotein and prohormone convertases: A family of subtilases generating diverse bioactive polypeptides. Brain Res 848:45-62
7. Couture F, D'Anjou F, Day R (2011) On the cutting edge of proprotein convertase pharmacology: From molecular concepts to clinical applications. Biomol Concepts 2:421-438
8. Becker GL, Lu Y, Hardes K, Strehlow B, Levesque C, Lindberg I, Sandvig K, Bakowsky U, Day R, Garten W, Steinmetzer T (2012) Highly potent inhibitors of the proprotein convertase furin as potential drugs for the treatment of infectious diseases. J Biol Chem 287(26):21992-22003
9. Fugere M, Day R (2005) Cutting back on proprotein convertases: The latest approaches to pharmacological inhibition. Trends Pharmacol Sci 26:294-301
10. D'Anjou F, Bergeron LJ, Larbi NB, Fournier I, Salzet M, Perreault JP, Day R (2004) Silencing of SPC2 expression using an engineered delta ribozyme in the mouse betaTC-3 endocrine cell line. J Biol Chem 279:14232-14239
11. Gupta N, Fisker N, Asselin MC, Lindholm M, Rosenbohm C, Orum H, Elmen J, Seidah NG, Straarup EM (2010) A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo. PLoS One 5:e10682
12. Scamuffa N, Siegfried G, Bontemps Y, Ma L, Basak A, Cherel G, Calvo F, Seidah NG, Khatib AM (2008) Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. J Clin Invest 118:352-363
13. Yuasa K, Masuda T, Yoshikawa C, Nagahama M, Matsuda Y, Tsuji A (2009) Subtilisin-like proprotein convertase PACE4 is required for skeletal muscle differentiation. J Biochem 146:407-415
14. Khatib AM, Siegfried G, Chretien M, Metrakos P, Seidah NG (2002) Proprotein convertases in tumor progression and malignancy: Novel targets in cancer therapy. Am J Pathol 160:1921-1935
15. Bergeron LJ, Reymond C, Perreault JP (2005) Functional characterization of the SOFA delta ribozyme. RNA 11:1858-1868
16. Bergeron LJ, Perreault JP (2005) Targetdependent on/off switch increases ribozyme fi delity. Nucleic Acids Res 33:1240-1248
17. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF (1978) Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21:274-281
18. Levesque MV, Perreault JP (2012) Targetinduced SOFA-HDV ribozyme. Methods Mol Biol 848:369-384
19. Levesque MV, Rouleau SG, Perreault JP (2011) Selection of the most potent specific on/off adaptor-hepatitis delta virus ribozymes for use in gene targeting. Nucleic Acid Ther 21:241-252
20. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK, Carpenter AE, Foo SY, Stewart SA, Stockwell BR, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE (2006) A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high- content screen. Cell 124:1283-1298
21. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD (2003) Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9:493-501
22. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D (1997) Multiply attenuated lentiviral vector achieves effi cient gene delivery in vivo. Nat Biotechnol 15:871-875
23. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D (1998) Selfinactivating lentivirus vector for safe and effi cient in vivo gene delivery. J Virol 72:9873-9880
24. Roehm NW, Rodgers GH, Hatfi eld SM, Glasebrook AL (1991) An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 142:257-265
25. Asif-Ullah M, Levesque M, Robichaud G, Perreault JP (2007) Development of ribozymebased gene-inactivations; the example of the hepatitis delta virus ribozyme. Curr Gene Ther 7:205-216
26. Akashi H, Matsumoto S, Taira K (2005) Gene discovery by ribozyme and siRNA libraries. Nat Rev Mol Cell Biol 6:413-422
27. Paddison PJ (2008) RNA interference in mammalian cell systems. Curr Top Microbiol Immunol 320:1-19
28. Sliva K, Schnierle BS (2010) Selective gene silencing by viral delivery of short hairpin RNA. Virol J 7:248